This CREB3L1-mediated signaling program is specifically activated in breast cancer cells when compared to their normal counterparts, representing a non-stress-dependent mechanism of the PERK branch of the ISR in cancer metastasis (45, 46). Here, EIF2AK3 is linked to cancer.